Medicare Part D coverage · sepiapterin · RxCUI 2723067
sepiapterin 1000 MG Oral Powder [Sephience]
Per the CMS 2026 Part D formulary file, sepiapterin 1000 MG Oral Powder [Sephience] is covered by 132 Medicare Part D plans (2.6% of enrollable products), averaging Tier 4, with prior authorization required on 75% of covering formularies.
- 2.6%
- Plan coverage
- 132
- Plans covering
- T4
- Avg tier
- 75%
- Prior auth required
What the CMS Formulary Data Shows for sepiapterin 1000 MG Oral Powder [Sephience]
Per the CMS 2026 Part D formulary file, sepiapterin 1000 MG Oral Powder [Sephience] (RxNorm concept RXCUI 2723067, generic name sepiapterin) appears on 8 distinct formulary files spanning 132 Medicare Part D plan offerings - 2.6% of enrollable Part D products, selective placement; verify formulary inclusion before enrolling. Tier placement ranges from Tier 1 to Tier 5, with a cross-plan average of Tier 4.
Real-world access to sepiapterin 1000 MG Oral Powder [Sephience] depends on utilization management as much as tier placement: 75% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.
Medicare Part D spending dashboard figures are not published for this drug. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry sepiapterin 1000 MG Oral Powder [Sephience] today.
Coverage Details
- Formularies covering
- 8
- Plans covering
- 132
- Coverage rate
- 2.6%
- Tier range
- Tier 1 – Tier 5
- Average tier
- Tier 4, Non-Preferred
Restrictions
- Prior authorization required
- 75% of formularies
- Step therapy required
- 0% of formularies
- Quantity limits
- 0% of formularies
Tier Distribution Across Plans
Medicare Advantage Plans (MA-PD) Covering sepiapterin 1000 MG Oral Powder [Sephience]
100 Medicare Advantage plans with Part D drug coverage include this drug.
Show the next 30 plans
Showing top 50 of 100 plans.
Frequently Asked Questions
Is sepiapterin 1000 MG Oral Powder [Sephience] covered by Medicare Part D?
Yes, sepiapterin 1000 MG Oral Powder [Sephience] is covered by 132 Medicare Part D plans (2.6% of all Part D formularies).
What tier is sepiapterin 1000 MG Oral Powder [Sephience] on Medicare Part D plans?
sepiapterin 1000 MG Oral Powder [Sephience] averages Tier 4 across Part D plans, ranging from Tier 1 to Tier 5.
Does sepiapterin 1000 MG Oral Powder [Sephience] require prior authorization?
75% of Part D formularies require prior authorization for sepiapterin 1000 MG Oral Powder [Sephience]. Step therapy: 0%. Quantity limits: 0%.
Read our methodology - how this data is sourced, computed, and verified.
Nationwide similar Part D drugs
Data-derived peers across the CMS Part D formulary extract: nearest average tier placement and nearest prior-authorization rate. Not therapeutic alternatives or same-generic strengths.
Closest average formulary tier
- dihydroergotamine mesylate 0.5 MG/ACTUAT Metered Dose Nasal Spray T4
- 0.5 ML darbepoetin alfa 0.2 MG/ML Prefilled Syringe [Aranesp] T4
- amoxicillin 250 MG / omeprazole 10 MG / rifabutin 12.5 MG Delayed Release Oral Capsule [Talicia] T4
- timolol hemihydrate 5 MG/ML Ophthalmic Solution [Betimol] T4
- deflazacort 18 MG Oral Tablet [Jaythari] T4
- bepotastine besilate 15 MG/ML Ophthalmic Solution [Bepreve] T4
Similar prior-authorization rate
- carbinoxamine maleate 0.8 MG/ML Oral Solution 75% PA
- 0.8 ML adalimumab-adaz 100 MG/ML Auto-Injector 75% PA
- cyclosporine 1 MG/ML Ophthalmic Suspension [Verkazia] 75% PA
- 1 ML octreotide 0.5 MG/ML Injection 75% PA
- 1 ML octreotide 0.05 MG/ML Injection 74.9% PA
- vigabatrin 100 MG/ML Oral Solution [Vigafyde] 75.1% PA